The AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders was held in Gothenberg, Sweden, spotlighting exciting news from another fantastic year of basic and clinical research in the neurodegenerative disease space. Speaking to expert presenters from across the globe, VJNeurology are delighted to bring you exclusive insights straight from the meeting!

Explore below!

View all videos

AD/PD 2023

28 Mar - 1 Apr, 2023

AD/PD 2023

28 Mar - 1 Apr, 2023

The AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders was held in Gothenberg, Sweden, spotlighting exciting news from another fantastic year of basic and clinical research in the neurodegenerative disease space. Speaking to expert presenters from across the globe, VJNeurology are delighted to bring you exclusive insights straight from the meeting!

Explore below!

View all videos

Browse Popular Uploads...

View all
10:55
Novel combination therapy PrimeC in ALS: biomarker data & launch of Phase II trial
Shiran Salomon-Zimri • 27 Mar 2023
7:08
Long-term follow up of LECIG use in Sweden
Dag Nyholm • 24 Mar 2023
6:10
Latest developments in Parkinson’s disease biomarkers
Andrea Pilotto • 23 Mar 2023
1:30
Cell- and gene-therapy landscape in Parkinson’s disease
Emma Lane • 29 Mar 2023

Parkinson's Disease Treatment... What's on the Horizon?

View all
2:37
Novel brain penetrant capsids for Parkinson’s disease gene therapy
Todd Carter • 29 Mar 2023
2:02
Phase I study of selnoflast to slow neurodegeneration in Parkinson’s disease
Gennaro Pagano • 5 Apr 2023
2:23
Key questions for cell and gene therapy trials in Parkinson’s disease
Emma Lane • 29 Mar 2023
2:34
Ongoing efforts to improve levodopa-based treatments in Parkinson’s disease
Dag Nyholm • 24 Mar 2023

Expert Perspectives

View all
1:17
Highlights of the AD/PD conference 2023
Tiago Outeiro • 25 Apr 2023
1:44
What is the significance of gastrointestinal involvement in Parkinson’s disease?
Dag Nyholm • 24 Mar 2023
2:03
What is the future of immunotherapy in Parkinson’s disease?
Gennaro Pagano • 5 Apr 2023
2:07
Future of tau-targeting immunotherapies in Alzheimer’s disease
Todd Carter • 29 Mar 2023
The content of VJNeurology is intended for healthcare professionals